Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Results of Annual General Meeting

30th Jun 2025 13:29

RNS Number : 0203P
Advanced Medical Solutions Grp PLC
30 June 2025
 

30 June 2025

 

Advanced Medical Solutions Group plc

("AMS" or the "Group")

 

Results of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company's Annual General Meeting held today at 11 am at the Offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QP, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 3 June 2025.

 

The poll results were as follows.

 

Resolution

Title

For

For %

Against

Against %

Total Votes

% Issued Capital

1

FINANCIAL STATEMENTS

135,778,231

100%

3,706

0.00%

135,781,937

61.93%

2

REMUNERATION REPORT

133,782,863

98.47%

2,082,282

1.53%

135,865,145

61.97%

3

AUDITOR REMUNERATION

134,051,574

98.61%

1,891,541

1.39%

135,943,115

62.01%

4

RE-ELECT G COOK

126,950,171

93.38%

8,992,839

6.62%

135,943,010

62.01%

5

RE-ELECT D LE FORT

128,280,815

94.36%

7,662,195

5.64%

135,943,010

62.01%

6

ELECT S SEARLE

135,889,875

99.96%

53,135

0.04%

135,943,010

62.01%

7

RE-ELECT C MEREDITH

134,405,209

98.87%

1,537,801

1.13%

135,943,010

62.01%

8

RE-ELECT E JOHNSON

133,759,281

98.39%

2,183,729

1.61%

135,943,010

62.01%

9

FINAL DIVIDEND

135,944,832

100%

1,706

0.00%

135,946,538

62.01%

10

ALLOT SHARES*

135,266,755

99.50%

679,783

0.50%

135,946,538

62.01%

11

PRE-EMPTION RIGHTS*

134,287,332

98.78%

1,658,642

1.22%

135,945,974

62.01%

12

PURCHASE SHARES*

134,630,774

99.98%

27,900

0.02%

134,658,674

61.42%

* Special Resolution

Notes:

1. Votes "For" and "Against" are expressed as a percentage of votes received.

2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

3. Total number of shares in issue at close of business on 26 June = 219,243,007 shares. 62.01% of the voting capital was instructed.

 

 

 

 

 

 

 

 

 

 

- End -

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations

 

 

 

ICR Healthcare

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Lucy Featherstone

[email protected]

Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Gary Clarence / David Anderson

 

 

Berenberg (Joint Broker)

Tel: +44 (0)20 3207 7800

Toby Flaux / Detlir Elezi / Yasmina Benchekroun

 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, LIQUIFIX™, Peters Surgical, Ifabond, Vitalitec and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label. Since 2019, the Group has made seven acquisitions: Sealantis, an Israeli developer of innovative internal sealants, Biomatlante, a French developer and manufacturer of surgical biomaterials, Raleigh, a leading UK coater and converter of woundcare and bio-diagnostics materials, AFS Medical, an Austrian specialist surgical business, Connexicon, an Irish tissue adhesives specialist, Syntacoll, a German specialist in collagen-based absorbable surgical implants and Peters Surgical, a global provider of specialty surgical sutures, mechanical haemostasis and internal cyanoacrylate devices.

 

AMS's products, manufactured in the UK, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, Austria, France, Poland, Benelux, India, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Ireland, Germany, France and Israel. Established in 1991, the Group has more than 1,600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSDIFESEISEEM

Related Shares:

Advanced Medical Solutions Group
FTSE 100 Latest
Value8,739.81
Change-21.15